Back to Journals » Lung Cancer: Targets and Therapy » Volume 3

Association of p21 Ser31Arg and p53 Arg72Pro polymorphisms with lung cancer risk in CAPUA study

Authors Souto-García A, Fernandez-Somoano A, Pascual T, Alvarez-Avellon, Tardon A

Received 22 June 2012

Accepted for publication 10 August 2012

Published 22 November 2012 Volume 2012:3 Pages 69—78


Checked for plagiarism Yes

Review by Single-blind

Peer reviewer comments 3

Ana Souto-García,1,2 Ana Fernández-Somoano,1,2 Teresa Pascual,3 Sara M Álvarez-Avellón,1,2 Adonina Tardón1,2

Molecular Epidemiolgy of Cancer Unit, University Institute of Oncology, University of Oviedo, Oviedo, Asturias, Spain; 2Consortium for Research in Epidemiology and Public Health (CIBERESP), Spain; 3Pneumology Department, Cabueñes Hospital, Gijón, Asturias, Spain

Background: The aim of this study was to investigate how Ser31Arg polymorphisms in p21 may modify lung cancer susceptibility. Because p21 is the major downstream mediator of p53, we analyzed the combined effect of two polymorphisms, p21 Ser31Arg and TP53 Arg72Pro, to elucidate whether polymorphic variants determine the risk of lung cancer.
Methods: This was designed as a hospital-based case-control study, and included 675 cases and 675 control subjects matched by ethnicity, gender, and age. Genotypes were determined by polymerase chain reaction restriction fragment length polymorphism, and multivariate unconditional logistic regression was performed to analyze the results.
Results: Subjects who carried the p21 Ser31Arg allele had a higher risk of lung cancer (adjusted odds ratio [OR] 1.38; 95% confidence interval [CI] 0.99–2.03). This risk was increased in men aged younger than 55 years (adjusted OR 2.35; 95% CI 1.00–5.51). Smokers had an increased risk of lung cancer (adjusted OR 2.23; 95% CI 1.24–4.02). Men younger than 55 years carrying risk alleles for both genes (p21 Ser31Arg and TP53 Arg72Pro) had an increased risk (adjusted OR 5.78; 95% CI 1.38–24.19), as did smokers with both risk alleles (adjusted OR 4.52; 95% CI 1.52–13.50).
Conclusion: The presence of both variant alleles increased the risk of developing lung cancer in men, particularly in smokers younger than 55 years.

Keywords: molecular epidemiology, cell cycle, tobacco, susceptibility, oncology

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]